The DOI matches its Crossref record; 472 of the 473 references it cites were found in a registry or an index.
History and progress of hypotheses and clinical trials for Alzheimer’s disease
Open accessAbstract
Alzheimer’s disease (AD) is a neurodegenerative disease characterized by progressive memory loss along with neuropsychiatric symptoms and a decline in activities of daily life. Its main pathological features are cerebral atrophy, amyloid plaques, and neurofibrillary tangles in the brains of patients. There are various descriptive hypotheses regarding the causes of AD, including the cholinergic hypothesis, amyloid hypothesis, tau propagation hypothesis, mitochondrial cascade hypothesis, calcium homeostasis hypothesis, neurovascular hypothesis, inflammatory hypothesis, metal ion hypothesis, and lymphatic system hypothesis. However, the ultimate etiology of AD remains obscure. In this review, we discuss the main hypotheses of AD and related clinical trials. Wealthy puzzles and lessons have made it possible to develop explanatory theories and identify potential strategies for therapeutic interventions for AD. The combination of hypometabolism and autophagy deficiency is likely to be a causative factor for AD. We further propose that fluoxetine, a selective serotonin reuptake inhibitor, has the potential to treat AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“AD can be categorized into two main types: familial (accounting for 1-5% of AD cases) and sporadic forms (over 95% of cases).76”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [76]
In the citing paper
“The most prevalent hypotheses are the Aβ cascade hypothesis, the inflammation hypothesis, the cholinergic hypothesis, the tau hypothesis, and the oxidative hypothesis [18,19,20].”
From The Multifaceted Role of Neuroprotective Plants in Alzheimer’s Disease Treatment (2022) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y., Jiang, Q. L., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,351
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Autophagy: Renovation of Cells and Tissues
Mizushima, N., & Komatsu, M. (2011) · Cell · doi:10.1016/j.cell.2011.10.026 · Cited by 6,615
Autophagy fights disease through cellular self-digestion
Mizushima, N., Levine, B., Cuervo, A. M., & Klionsky, D. J. (2008) · Nature · doi:10.1038/nature06639 · Cited by 6,452
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
IDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
Iliff, J. J., Wang, M., Liao, Y., Plogg, B. A., Peng, W., Gundersen, G. A., Benveniste, H., Vates, G. E., Deane, R., Goldman, S. A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003748 · Cited by 5,824
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Research works printed but not linked: 3
- Dementia – caring, ethics, ethnical and economical aspects: a systematic review. Stockholm: Swedish Council on Health Technology Assessment (SBU). SBU No. 172 (2008).
- Liu, B. et al. Preparation and identification of a series of mannose glucuronic acid oligosaccharides. Chem. J. Chin. Univ. 27, 485–487 (2006).
- M, G. GV-971, a new drug against Alzheimer’s disease. Chin. J. Pharmacol Toxicol. 31, 459–460 (2017).
Cited by
Sorted by citations
Items 701–732 of 732
Apolipoprotein E and infectious diseases: A framework for therapeutic developments
Viswalingam, V., Kumar, D., Tewari, S., & Ganeshpurkar, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40563-1.00018-1
Yan, J., Wei, Z., Chen, R., & Cao, Y. (2026) · BMC Geriatrics · doi:10.1186/s12877-026-07956-z
Li, T., Chang, Y., Tang, S., Chen, Y., Li, X., & Wang, Y. (2026) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2026.112062
Eluigwe, K. N., Okoye, N. A., Olatunji, O. L., & Oka, O. U. (2026) · Journal of Applied Gerontology · doi:10.1177/07334648261470134
Hernández, D. L. P., Sánchez, Á. A. L., & Juárez, R. G. (2026) · Casos y Revisiones de Salud · doi:10.22201/fesz.26831422e.2026.8.1.6
Targeting Mitochondria for Postoperative Cognitive Dysfunction: From Mechanisms to Therapeutics
Zhang, A., Zhao, A., Fan, G., He, L., & Qi, S. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06120-3
Wang, X., Liu, Y., Liu, J., Wang, R., Zheng, J., Deng, Z., Song, K., Zhang, D., Wang, C., Zhu, K., et al. (2026) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2026.109675
Kumawat, A., Sharma, M. M., & Nathani, S. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02369-1
Synthesis, molecular modeling, and AChE/BChE inhibitory activity of novel phthalonitriles
Tekin, A., Mercan, E. Ö., & Arslan, T. (2026) · Journal of Anatolian Environmental and Animal Sciences · doi:10.35229/jaes.1929402
Alzheimer’s disease: genetic background in the era of next-generation sequencing technologies
Lukyova, L., Zaťková, A., Minařík, J., Holesova, Z., Budiš, J., Kucharík, M., Beneš, V., Gazdarica, J., & Szemes, T. (2026) · Brain Communications · doi:10.1093/braincomms/fcag332
Impact of natural compounds in Caenorhabditis elegans models of neurodegenerative diseases
Huang, Q. (2026) · Investigo repository of University of Vigo (University of Vigo) · doi:10.35869/11093/12663
Lahouel, A., Harrouche, K., Oğuz, E., Türkan, F., Çetin, A., & Khelili, S. (2026) · Neuropharmacology · doi:10.1016/j.neuropharm.2026.111199
Vijayan, D., Siva, K., Ramachandran, J., & Saravanan, D. (2026) · Malaysian Applied Biology · doi:10.55230/mabjournal.v55i3.3751
Wang, Y., Chen, X., Shi, J., Zhang, W., & Liu, R. (2026) · Materials & Design · doi:10.1016/j.matdes.2026.117140
The role of acupuncture in the dendritic cell vaccine against Alzheimer's disease
Hong, Y., Shen, N., Yang, H., Ahmed, G., Regmi, D., Lin, X., Guo, N., Hearn, G., Sawmiller, D. R., & Cao, C. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261490135
Xu, X., Xu, X., Zhou, L., Wang, W., Ouyang, M., Zheng, J., & Zhang, L. (2026) · Analytica Chimica Acta · doi:10.1016/j.aca.2026.346374
Kamonnat, C., Thongdechsri, S., Kraokaew, P., Niamnont, N., Sobhon, P., & Meemon, K. (2026) · Oxidative Medicine and Cellular Longevity · doi:10.1155/omcl/1471919
Computational Analysis of Serpentine and its structural stereoisomers as promising BACE 1 Inhibitors
Srivastava, S., & Kumar, P. (2026) · International Conference on Innovative Sustainable Computational Technologies (CISCT) · doi:10.1109/cisct69589.2026.11726910
Malakar, V. K., Raman, R., Justin, A., Dhanabal, S. P., Roy, D., Malakar, C. C., Purohit, D., & Mali, P. C. (2026) · 3 Biotech · doi:10.1007/s13205-026-05086-2
Zainuddin, M.-S., Wei, A. C., Bhuvanendran, S., & Azman, A. S. (2026) · Beni-Suef University Journal of Basic and Applied Sciences · doi:10.1186/s43088-026-00842-y
Sabbir, M. G., & Hsiao, K. (2026) · Cells · doi:10.3390/cells15211941
Brain insulin resistance and microglial immunometabolic dysregulation in neurodegenerative diseases
Liu, X., Zhang, X., Su, Y., Guan, G., Luo, X., & Zhang, P. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.2002283
Unraveling the role of CARM1 in Alzheimer’s disease: molecular mechanisms and therapeutic potential
Gupta, S. K., & Aran, K. R. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02435-8
Metadata
- Authors
- Liu, P.-P., Xie, Y., Meng, X.-Y., & Kang, J.-S.
- Affiliations
- First Affiliated Hospital of Zhengzhou University (CN)
- Corresponding author
- Kang, Jian-Sheng
- Venue
- Signal Transduction and Targeted Therapy
- Published
- 2019-08-23
- Volume
- 4
- Issue
- 1
- Pages
- 29-29
- ISSN
- 2059-3635 (ISSN-L)
- PMC
- PMC6799833
- OpenAlex
- W2969562288
- Cited by
- 723
- References
- 473
- Citations by year
- 2026: 54 · 2025: 94 · 2024: 146 · 2023: 124 · 2022: 130 · 2021: 106 · 2020: 66 · 2019: 3
- FWCI
- 9.02
- Type
- journal article
- Language
- en
- Update notices
- correction (2019-09-23)
- Open access
- gold
- doi.org
- Locations
- Signal Transduction and Targeted Therapy (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Natural Science Foundation of China (31171369)
- the Chinese Academy of Sciences
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, amyloid hypothesis, cholinergic hypothesis, neuroinflammation, calcium homeostasis, brain hypometabolism, autophagy dysfunction, fluoxetine, selective serotonin reuptake inhibitors, clinical trials, therapeutic interventions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
